Canaccord Genuity analyst Matt Bottomley maintained a Buy rating on MediPharm Labs (MEDIF) today and set a price target of C$2.25.

After RBC Capital and J.P.

B.Riley FBR analyst Eric Wold upgraded Marcus (MCS) to Buy today and set a price target of $27.

Analysts fell to the sidelines weighing in on General Mills (GIS) and Capri Holdings (CPRI) with neutral ratings, indicating that the experts are …

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on BNY Mellon (BK) and Brookfield Property …

Morgan Stanley analyst Michael Cyprys maintained a Hold rating on Virtus Investment Partners (VRTS) today and set a price target of $128.00.

Analysts have been eager to weigh in on the Financial sector with new ratings on Blackrock (BLK), E*Trade Financial (ETFC) and Regency Centers …

In a report released today, Mike Crawford from B.Riley FBR maintained a Buy rating on Widepoint (WYY), with a price target of $0.

After Oppenheimer and RBC Capital gave Provention Bio (NASDAQ: PRVB) a Buy rating last month, the company received another Buy, this time from …

In a report issued on June 29, Lucas Pipes from B.Riley FBR maintained a Hold rating on Contura Energy (CTRA), with a price …